SM17, a new IL-17RB-targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
Allergy
.
2024 Apr 9.
doi: 10.1111/all.16120.
Online ahead of print.
Authors
Lik Hang Lam
1
,
Weimin Li
1
,
Wai Chung Wu
1
,
Kai Cheung Chow
1
,
Wai Yin Dennis Au
1
,
Guolin Xu
2
,
Ge Wang
2
,
Xuchen Qian
2
,
Ka Man Ng
3
,
Shaik Abdullah Nawabjan
3
,
Muthu Iswarya Gandhi Sethuraman
3
,
Wai Yan Choi
3
,
Billy Kwok Chong Chow
3
,
Shui On Leung
1
,
Chin Wai Hui
1
Affiliations
1
SinoMab BioScience Limited, Hong Kong, China.
2
MediNexus Pharma (Suzhou) Limited, Suzhou, Jiangsu, China.
3
School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
PMID:
38590291
DOI:
10.1111/all.16120
No abstract available
Publication types
Letter
Grants and funding
SinoMab BioScience Limited